Cambrex Corp (CBM) 21.04 $CBM
Healthcare Companies Report Regulatory Affirmations, MPA Inspections, Enrollment in Trials, Stock Movements - Analyst Notes on Halozyme, Align Technology, Cambrex, Receptos, and Anacor Pharmaceuticals
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Halozyme Therapeutics, Inc. (NASDAQ: HALO), Align Technology Inc. (NASDAQ: ALGN), Cambrex Corporation. (NYSE: CBM), Receptos, Inc. (NASDAQ: RCPT), and Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Flow Chemistry Market by Reactor, Application & Geography - Trends & Forecast to 2018
M2 - Thu Apr 03, 6:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l79qk9/flow_chemistry) has announced the addition of the "Global Flow Chemistry Market by Reactor, Application & Geography - Trends & Forecast to 2018" report to their offering. The market was estimated at $709.5 million and expected to reach $1,216.1 million by 2018 growing at CAGR of 9.4%, with MRT systems growing the fastest This report estimates the market size of the global Flow Chemistry devices market in terms of value It discusses market drivers, restraints and opportunity, and price trends.. The value chain analysis, cost analysis, and the Porter's analysis gives further insight into the impact factors in the industry sector. The report tracks the recent activities of market players in terms of product launches, expansion plans, supply contracts, and partnerships and collaborations. In addition, the top 13 players of the Flow chemistry market have been profiled in this report, and based on the study of these competitors a winning imperative has been sketched. The continuous flow reactor market is witnessing a significant growth globally, due to various unique advantages when compared to the traditional batch reactors. The types of continuous flow reactors discussed in the report are Micro Reactor systems (MRT), Continuous Stirred Tank Reactors (CSTR), Plug Flow Reactors (PFR), and Microwave systems. A wide range of applications that cater to various industries such as Chemicals, Pharmaceuticals, Petro Chemicals, Bio fuels, Perfume and Fragrance Industries, Academia research and laboratories, etc. have also been studied in the report. Under the MRT system segment, chip, capillary, and microstructured-based systems have been taken into consideration. Due to the evolution of energy savings regulations, cGMPs (current good manufacturing practices), environmental and safety laws, etc., companies are adopting sustainable production techniques. Also, the chemicals and pharmaceuticals industries, which are end users of flow reactors, are growing at a significant pace globally, owing to the rising per capita income of medical products, the ever growing population, rising per capita income, etc. Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Continuous Flow Reactors Market, By Type - Continuous Flow Reactors Market, By Geography - Competitive Landscape - Company Profiles - Am Technology - Cambrex Corporation - Chemtrix Bv - Dsm - Ehrfeld Mikrotechnik Bts - Future Chemistry Holding Bv - Imm - Little Things Factory - Lonza Group Ltd. - Milestone Srl - Syrris - Terra Labs - Thalesnano Inc. - Uniqsis Ltd. - Velocys - Ymc Co. Ltd. For more information visit http://www.researchandmarkets.com/research/l7..._chemistry
Cambrex To Present At The 13th Annual Needham Healthcare Conference
PR Newswire - Wed Apr 02, 11:37AM CDT
Cambrex Corporation (NYSE: CBM, "Cambrex"
is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the 13th Annual Needham Healthcare Conference on April 9, 2014 at 4:20 p.m. EDT in New York City.
Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 8:46AM CDT
Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as the company saw its shares shoot up nearly 13% on the day.
MEI Pharma, Inc. (MEIP) in Focus: Stock up 12.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:44AM CDT
MEI Pharma, Inc. was a big mover last session, as the company saw its shares rise over 12% on the day.
Keryx Biopharmaceuticals Inc. (KERX) Worth Watching: Stock Surges 17.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:44AM CDT
Keryx Biopharmaceuticals Inc. was a big mover last session, as the company saw its shares shoot up over 17% on the day.
Galectin Therapeutics, Inc. (GALT) in Focus: Stock Moves Up 8.84% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:44AM CDT
Galectin Therapeutics, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day.
AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 8:39AM CDT
AVEO Pharmaceuticals, Inc. was a big mover last session, as its shares rose over 7% on the day.
Cambrex Keeps Its Pipeline Of New Products Flowing
at Investor's Business Daily - Fri Mar 21, 3:50PM CDT
For most pharmaceutical companies, keeping a pipeline of new drugs filled is critical to success. Steven Klosk, president and CEO of East Rutherford, N.J.-based Cambrex (CBM), specializes in developing a pipeline of new medications as an outsourcer...
Sinovac Biotech (SVA) Soars: Stock Rises 17.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 8:39AM CDT
Sinovac Biotech Ltd. was a big mover last session, as its shares rose over 17% on the day.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:44AM CDT
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise 9.5% on the day.
Synthetic Biologics Inc. (SYN) in Focus: Stock up 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 8:04AM CDT
Synthetic Biologics Inc. was a big mover last session, as the company saw its shares rise over 9% on the day
Sequenom (SQNM) Soars: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:51AM CDT
Sequenom Inc. was a big mover last session, as its shares rose over 6% on the day.
Oncothyreon Inc. (ONTY) in Focus: Stock up 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:44AM CDT
Oncothyreon Inc. was a big mover last session, as the company saw its shares rise slightly over 6% on the day.
Durata Therapeutics, Inc. (DRTX) in Focus: Stock Up 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 7:44AM CDT
Durata Therapeutics, Inc. was a big mover last session, as the company saw its shares jump 5.4% on the day.
Geron Corporation (GERN) in Focus: Stock Moves 5.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 7:44AM CDT
Geron Corporation was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Acura Pharmaceuticals, Inc. (ACUR) in Focus: Stock Moves 7.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:44AM CDT
Acura Pharmaceuticals, Inc. (ACUR) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
Enzymotec Ltd. (ENZY) in Focus: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:44AM CDT
Enzymotec Ltd. was a big mover last session, as the company saw its shares rise a little over 5% on the day.
The Global API Market is Expected to Grow at a CAGR of Around 8% during 2012-2017
M2 - Tue Mar 11, 11:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3wnnb7/global_api_market) has announced the addition of the "Global API Market Forecast to 2017" report to their offering. The market for Active Pharmaceutical Ingredients is brimming with activities. While it is consolidating in US and EU resulting in the emergence of few big players producing specialty APIs that target high value markets, new players are entering in the mass markets of India and China. With global healthcare spending to have reached around US$ 6.4 Trillion in 2010 and a rapidly ageing population boosting the demand for pharmaceuticals, APIs represent one of the most exciting markets for growth. In this latest research study, "Global API Market Forecast to 2017", the authors identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 113 Billion in 2012, is expected to grow at a CAGR of around 8% during 2012-2017. For this study, the authors have analyzed the global API market from different perspectives. It has been studied at the Captive vs. Merchant level; Branded vs. Generic level and Synthetic vs. Biotech level. This has been done to provide a thorough and apt assessment to players who can use the research findings to support their business strategies. At the regional level, the authors have provided a thorough understanding of the merchant API markets along with their future outlook to 2017. Each region's market is unique with exports playing a major role in regions of India and China. Each region's regulatory environment has also been elaborated, while discussing various drivers and challenges, to help new entrants overcome entry barriers. The report also provides a comparative analysis of key regions highlighting labor cost and productivity; price structure with reference to manufacturing indicators of profit margins, raw materials and conversion costs; and investment incurred in plant setups. These research findings will aid international players to strategically expand their presence globally. Companies Mentioned: - Aurobindo Pharma Limited - BASF SE - Boehringer Ingelheim GmbH - Cambrex Corporation - Cipla - Daiichi Fine Chemicals - Divis Laboratories Limited - Dr Reddy's Laboratories - Fabbrica Italiana Sintetici - Lonza - Pfizer CentreSource - Ranbaxy Laboratories - Royal DSM - Teva Active Pharmaceutical Ingredients - Zhejiang Hisun Pharmaceutical Co. Ltd. For more information visit http://www.researchandmarkets.com/research/3w...api_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
IGI, Laboratories, Inc. (IG) in Focus: Stock up 11.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:44AM CDT
IGI, Laboratories, Inc. was a big mover last session, as the company saw its shares surge nearly 12% on the day.
Healthcare Companies Report Regulatory Affirmations, MPA Inspections, Enrollment in Trials, Stock Movements - Analyst Notes on Halozyme, Align Technology, Cambrex, Receptos, and Anacor Pharmaceuticals
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Halozyme Therapeutics, Inc. (NASDAQ: HALO), Align Technology Inc. (NASDAQ: ALGN), Cambrex Corporation. (NYSE: CBM), Receptos, Inc. (NASDAQ: RCPT), and Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Flow Chemistry Market by Reactor, Application & Geography - Trends & Forecast to 2018
M2 - Thu Apr 03, 6:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l79qk9/flow_chemistry) has announced the addition of the "Global Flow Chemistry Market by Reactor, Application & Geography - Trends & Forecast to 2018" report to their offering. The market was estimated at $709.5 million and expected to reach $1,216.1 million by 2018 growing at CAGR of 9.4%, with MRT systems growing the fastest This report estimates the market size of the global Flow Chemistry devices market in terms of value It discusses market drivers, restraints and opportunity, and price trends.. The value chain analysis, cost analysis, and the Porter's analysis gives further insight into the impact factors in the industry sector. The report tracks the recent activities of market players in terms of product launches, expansion plans, supply contracts, and partnerships and collaborations. In addition, the top 13 players of the Flow chemistry market have been profiled in this report, and based on the study of these competitors a winning imperative has been sketched. The continuous flow reactor market is witnessing a significant growth globally, due to various unique advantages when compared to the traditional batch reactors. The types of continuous flow reactors discussed in the report are Micro Reactor systems (MRT), Continuous Stirred Tank Reactors (CSTR), Plug Flow Reactors (PFR), and Microwave systems. A wide range of applications that cater to various industries such as Chemicals, Pharmaceuticals, Petro Chemicals, Bio fuels, Perfume and Fragrance Industries, Academia research and laboratories, etc. have also been studied in the report. Under the MRT system segment, chip, capillary, and microstructured-based systems have been taken into consideration. Due to the evolution of energy savings regulations, cGMPs (current good manufacturing practices), environmental and safety laws, etc., companies are adopting sustainable production techniques. Also, the chemicals and pharmaceuticals industries, which are end users of flow reactors, are growing at a significant pace globally, owing to the rising per capita income of medical products, the ever growing population, rising per capita income, etc. Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Continuous Flow Reactors Market, By Type - Continuous Flow Reactors Market, By Geography - Competitive Landscape - Company Profiles - Am Technology - Cambrex Corporation - Chemtrix Bv - Dsm - Ehrfeld Mikrotechnik Bts - Future Chemistry Holding Bv - Imm - Little Things Factory - Lonza Group Ltd. - Milestone Srl - Syrris - Terra Labs - Thalesnano Inc. - Uniqsis Ltd. - Velocys - Ymc Co. Ltd. For more information visit http://www.researchandmarkets.com/research/l7..._chemistry
Cambrex To Present At The 13th Annual Needham Healthcare Conference
PR Newswire - Wed Apr 02, 11:37AM CDT
Cambrex Corporation (NYSE: CBM, "Cambrex"
is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the 13th Annual Needham Healthcare Conference on April 9, 2014 at 4:20 p.m. EDT in New York City. Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 8:46AM CDT
Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as the company saw its shares shoot up nearly 13% on the day.
MEI Pharma, Inc. (MEIP) in Focus: Stock up 12.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:44AM CDT
MEI Pharma, Inc. was a big mover last session, as the company saw its shares rise over 12% on the day.
Keryx Biopharmaceuticals Inc. (KERX) Worth Watching: Stock Surges 17.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:44AM CDT
Keryx Biopharmaceuticals Inc. was a big mover last session, as the company saw its shares shoot up over 17% on the day.
Galectin Therapeutics, Inc. (GALT) in Focus: Stock Moves Up 8.84% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:44AM CDT
Galectin Therapeutics, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day.
AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 8:39AM CDT
AVEO Pharmaceuticals, Inc. was a big mover last session, as its shares rose over 7% on the day.
Cambrex Keeps Its Pipeline Of New Products Flowing
at Investor's Business Daily - Fri Mar 21, 3:50PM CDT
For most pharmaceutical companies, keeping a pipeline of new drugs filled is critical to success. Steven Klosk, president and CEO of East Rutherford, N.J.-based Cambrex (CBM), specializes in developing a pipeline of new medications as an outsourcer...
Sinovac Biotech (SVA) Soars: Stock Rises 17.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 8:39AM CDT
Sinovac Biotech Ltd. was a big mover last session, as its shares rose over 17% on the day.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:44AM CDT
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise 9.5% on the day.
Synthetic Biologics Inc. (SYN) in Focus: Stock up 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 8:04AM CDT
Synthetic Biologics Inc. was a big mover last session, as the company saw its shares rise over 9% on the day
Sequenom (SQNM) Soars: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:51AM CDT
Sequenom Inc. was a big mover last session, as its shares rose over 6% on the day.
Oncothyreon Inc. (ONTY) in Focus: Stock up 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:44AM CDT
Oncothyreon Inc. was a big mover last session, as the company saw its shares rise slightly over 6% on the day.
Durata Therapeutics, Inc. (DRTX) in Focus: Stock Up 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 7:44AM CDT
Durata Therapeutics, Inc. was a big mover last session, as the company saw its shares jump 5.4% on the day.
Geron Corporation (GERN) in Focus: Stock Moves 5.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 7:44AM CDT
Geron Corporation was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Acura Pharmaceuticals, Inc. (ACUR) in Focus: Stock Moves 7.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:44AM CDT
Acura Pharmaceuticals, Inc. (ACUR) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
Enzymotec Ltd. (ENZY) in Focus: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:44AM CDT
Enzymotec Ltd. was a big mover last session, as the company saw its shares rise a little over 5% on the day.
The Global API Market is Expected to Grow at a CAGR of Around 8% during 2012-2017
M2 - Tue Mar 11, 11:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3wnnb7/global_api_market) has announced the addition of the "Global API Market Forecast to 2017" report to their offering. The market for Active Pharmaceutical Ingredients is brimming with activities. While it is consolidating in US and EU resulting in the emergence of few big players producing specialty APIs that target high value markets, new players are entering in the mass markets of India and China. With global healthcare spending to have reached around US$ 6.4 Trillion in 2010 and a rapidly ageing population boosting the demand for pharmaceuticals, APIs represent one of the most exciting markets for growth. In this latest research study, "Global API Market Forecast to 2017", the authors identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 113 Billion in 2012, is expected to grow at a CAGR of around 8% during 2012-2017. For this study, the authors have analyzed the global API market from different perspectives. It has been studied at the Captive vs. Merchant level; Branded vs. Generic level and Synthetic vs. Biotech level. This has been done to provide a thorough and apt assessment to players who can use the research findings to support their business strategies. At the regional level, the authors have provided a thorough understanding of the merchant API markets along with their future outlook to 2017. Each region's market is unique with exports playing a major role in regions of India and China. Each region's regulatory environment has also been elaborated, while discussing various drivers and challenges, to help new entrants overcome entry barriers. The report also provides a comparative analysis of key regions highlighting labor cost and productivity; price structure with reference to manufacturing indicators of profit margins, raw materials and conversion costs; and investment incurred in plant setups. These research findings will aid international players to strategically expand their presence globally. Companies Mentioned: - Aurobindo Pharma Limited - BASF SE - Boehringer Ingelheim GmbH - Cambrex Corporation - Cipla - Daiichi Fine Chemicals - Divis Laboratories Limited - Dr Reddy's Laboratories - Fabbrica Italiana Sintetici - Lonza - Pfizer CentreSource - Ranbaxy Laboratories - Royal DSM - Teva Active Pharmaceutical Ingredients - Zhejiang Hisun Pharmaceutical Co. Ltd. For more information visit http://www.researchandmarkets.com/research/3w...api_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
IGI, Laboratories, Inc. (IG) in Focus: Stock up 11.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:44AM CDT
IGI, Laboratories, Inc. was a big mover last session, as the company saw its shares surge nearly 12% on the day.
